Cornerstone Capital Management Holdings’s Immunogen Inc IMGN Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-48,200	Closed	-$129K	–	1439
2016 Q3	$129K	Buy	48,200 +12,112	+34%	+$35.2K	﹤0.01%	1235
2016 Q2	$111K	Sell	36,088 -91,212	-72%	-$572K	﹤0.01%	1262
2016 Q1	$1.08M	Sell	127,300 -100,403	-44%	-$849K	0.01%	892
2015 Q4	$3.09M	Buy	227,703 +108,703	+91%	+$1.34M	0.03%	599
2015 Q3	$1.14M	Buy	119,000 +95,600	+409%	+$1.4M	0.01%	852
2015 Q2	$336K	Buy	23,400 +9,100	+64%	+$100K	﹤0.01%	1092
2015 Q1	$128K	Sell	14,300 -200	-1%	-$1.45K	﹤0.01%	1237
2014 Q4	$88K	Buy	14,500 +13,900	+2,317%	+$127K	﹤0.01%	1174
2014 Q3	$6K	Buy	+600	New	+$6.79K	﹤0.01%	1254

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cornerstone Capital Management Holdings's IMGN Position: Q4 2016 in Review

Cornerstone Capital Management Holdings sold out of Immunogen Inc (IMGN) in Q4 2016, closing a stake of 48,200 shares — an estimated $129K sold.

Cornerstone Capital Management Holdings first reported a position in IMGN in Q3 2014 and held it in 9 quarters. The position peaked at $3.09M in Q4 2015. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

Cornerstone Capital Management Holdings reported no remaining Immunogen Inc position as of Q4 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 48,200 Immunogen Inc shares in Q4 2016, an estimated $129K.
Cornerstone Capital Management Holdings first reported a position in Immunogen Inc in Q3 2014 and held it in 9 quarters.
Cornerstone Capital Management Holdings's Immunogen Inc position peaked at $3.09M in Q4 2015.
156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.